Ellen L. Goode

Mayo Clinic — United States

Medicine · Health Sciences

82h-index28.4kcitations988works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(456), Cancer-related molecular mechanisms research(178), RNA modifications and cancer(104), BRCA gene mutations in cancer(102), Genetic Associations and Epidemiology(98)

Publications923 total

Genomic characterization of colorectal tumors: insights into significantly mutated genes, pathways, and survival outcomes
BMC Cancer·2025Open Access
Supplementary Table 5 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Table 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Table 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Methods 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Figure 1 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Table 6 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Figure 2 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Figure 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Table 3 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Figure 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Table 4 from Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma
2025Open Access
Supplementary Figures S1-S4 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
2025Open Access
Supplementary Tables S1-S5 from The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas
2025Open Access
Abstract B046: Homologous recombination DNA repair dependent survival associations in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis consortium study
Cancer Research·2025
Assessing genotype−phenotype correlations in colorectal cancer with deep learning: a multicentre cohort study
The Lancet Digital Health·2025· 3 citedOpen Access
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
EBioMedicine·2025· 1 citedOpen Access
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
Gynecologic Oncology·2025· 2 citedOpen Access
Table S3 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
2025Open Access
Figure S1 from Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes
2025Open Access
page 1 of 47Next →

Frequent Co-authors

Brooke L. Fridley(18), Susan J. Ramus(18), Julie M. Cunningham(17), Paul D.P. Pharoah(16), Estrid Høgdall(15), Jenny Chang‐Claude(14), Jolanta Lissowska(13), Susanne K. Kjær(13), Honglin Song(13), Joellen M. Schildkraut(12), Simon A. Gayther(12), Aleksandra Gentry‐Maharaj(12), Alice S. Whittemore(12), Georgia Chenevix‐Trench(11), Louise A. Brinton(11), Robert A. Vierkant(11), Montserrat García‐Closas(10), Jennifer A. Doherty(10), Marc T. Goodman(10), Allan Jensen(10)